Search

for
Search:

Did you mean TYK2 Inhibitor?

GlossaryTYK2 Inhibitor

blocks enzyme activity to reduce inflammation in autoimmune diseases

A TYK2 inhibitor is a type of medication that blocks the activity of the TYK2 enzyme, which is involved in the immune system's signaling pathways. By inhibiting this enzyme, these drugs can help reduce inflammation and are being researched for treating autoimmune diseases like psoriasis and alopecia areata.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 161 results

research Jak 1-3 Inhibitors and Tyk-2 Inhibitors in Dermatology: Practical Pearls for the Primary Care Physician

6 citations , October 2024 in “Journal of Family Medicine and Primary Care”

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

research Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata

49 citations , February 2022 in “Drug Design Development and Therapy”

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

research Review of Promising Off-Label Use of Deucravacitinib

September 2025 in “International Journal of Molecular Sciences”

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

research Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives

December 2025 in “Cosmetics”

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

research Alopecia Areata: Diagnostic and Therapeutic Recommendations of the Polish Society of Dermatology. Part 2: Treatment

1 citations , January 2023 in “Przegląd Dermatologiczny”

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

View more "tyk-2 inhibitors" in research →

Community Join

0 / 0 results

— no results